NDC 50090-7406-01 - Glimepiride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-7406
- Requested NDC
- 50090-7406-01
- Package NDCs from labels
- 50090-7406-0, 50090-7406-1, 50090-7406-2, 50090-7406-3, 50090-7406-4, 50090-7406-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2024-10-25
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Glimepiride - A-S Medication Solutions | A-S Medication Solutions | 2024-10-25 | Human Prescription Drug Label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-7406-0 | Glimepiride | 30 in 1 BOTTLE | TABLET | 30 | 3 | |
| 50090-7406-1 | Glimepiride | 100 in 1 BOTTLE | TABLET | 100 | 3 | |
| 50090-7406-2 | Glimepiride | 60 in 1 BOTTLE | TABLET | 60 | 3 | |
| 50090-7406-3 | Glimepiride | 90 in 1 BOTTLE | TABLET | 90 | 3 | |
| 50090-7406-4 | Glimepiride | 180 in 1 BOTTLE | TABLET | 180 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-7406 | GLIMEPIRIDE TABLET [A-S MEDICATION SOLUTIONS] | 3 | Current NDC, 5 package rows | 20241027_79ee7533-f75d-4c49-b396-b339654f5c44.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-7406-0 | EA - Each | 50090-7406 | 2f61a8d8-6261-4b86-a0d5-e780a2e1ac7a | 1 | 2024-12-10 |
| 50090-7406-1 | EA - Each | 50090-7406 | 8c17d3a2-58e2-4521-8f73-9c0079f45c0f | 1 | 2024-12-10 |
| 50090-7406-2 | EA - Each | 50090-7406 | e168ba01-bc43-4728-9fb2-01eabb2c2a5e | 1 | 2024-12-10 |
| 50090-7406-3 | EA - Each | 50090-7406 | ef70b145-eb95-48a1-8253-5b45ec9f8828 | 1 | 2024-12-10 |
| 50090-7406-4 | EA - Each | 50090-7406 | f50e9cc8-16af-4ef9-8432-39cda6bcaa4f | 1 | 2024-12-10 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Meijer Advanced Redness and Irritation Relief | DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HCI | Meijer Distribution, Inc. | 9fea6d7a-a2cd-d26e-e053-2995a90a15f8 | 2023-12-22 | Warnings | FZ989GH94E |
| Walgreens Eye Drops Advanced Relief 15mL | DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HCI | Walgreen Company | 949f5560-fba7-2da8-e053-2995a90a23c2 | 2023-12-20 | Warnings | FZ989GH94E |
| Signature Care Eye Drops Advanced Relief | DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HCL | Better Living Brands LLC | 5d7228ce-f108-4cc2-9aec-8b4548c3a155 | 2023-12-20 | Warnings | FZ989GH94E |
| Kroger Eye Drops Advanced Relief | DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HYDROCHLORIDE | Kroger Company | f7ad77fc-d890-25b9-e053-6394a90a2b12 | 2023-12-20 | Warnings | FZ989GH94E |
| Equaline Advanced Relief Eye Drops | DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HYDROCHLORIDE | United Natural Foods, Inc. | f7602789-179a-edfc-e053-6294a90a0844 | 2023-12-20 | Warnings | FZ989GH94E |
| Topcare Health Artificial Tears | POLYVINYL ALCOHOL, POVIDONE | Topco Associates LLC | 9c614c0e-5862-682f-e053-2a95a90abc09 | 2023-12-20 | Warnings | FZ989GH94E |
| TopCare Health Advanced Moisturizing Plus Redness Relief | DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HCL | Topco Associates LLC | 9c6193a6-d822-1b27-e053-2995a90ab3cf | 2023-12-20 | Warnings | FZ989GH94E |
| HEB Advanced Eye Drops | DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HYDROCHLORIDE | HEB Grocery Company, LP | f76281d6-3aea-349b-e053-6394a90afca2 | 2023-12-20 | Warnings | FZ989GH94E |
| Glimepiride | GLIMEPIRIDE | A-S Medication Solutions | be772fca-1579-4fba-a4b7-04b970d09e45 | 2023-12-17 | Warnings, Adverse reactions | 199246 6KY687524K |
| Glimepiride | GLIMEPIRIDE | A-S Medication Solutions | 0a1eaf23-d5fd-4b3e-96c5-68ff16f0033b | 2023-12-14 | Warnings, Adverse reactions | 199246 6KY687524K |
| Glimepiride | GLIMEPIRIDE | A-S Medication Solutions | a9461830-1c4f-4bc4-b622-1c44112a76b9 | 2023-12-03 | Warnings, Adverse reactions | 199247 6KY687524K |
| Good Neighbor Pharmacy Artifical Tears Lubricant Eye Drops | POLYVINYL ALCOHOL, POVIDONE | Proficient Rx LP | 73e12596-6dd5-4cd2-83ed-992e1211b4b8 | 2023-12-01 | Warnings | FZ989GH94E |
| Glimepiride | GLIMEPIRIDE | A-S Medication Solutions | a11680ba-2750-43ab-a1b1-a52ebe3e139f | 2023-09-06 | Warnings, Adverse reactions | 199247 6KY687524K |
| Glimepiride | GLIMEPIRIDE | A-S Medication Solutions | e8da2484-43a7-4dcb-84d5-d84596feb9f6 | 2023-08-31 | Warnings, Adverse reactions | 199245 6KY687524K |
| Glimepiride | GLIMEPIRIDE | A-S Medication Solutions | def20e38-01f7-4ead-beb6-3dc11062a342 | 2023-06-22 | Warnings, Adverse reactions | 199247 6KY687524K |
| Glimepiride | GLIMEPIRIDE | Proficient Rx LP | 8f687fa6-54eb-4556-8ea6-aafec49a87d1 | 2023-03-01 | Warnings, Adverse reactions | 199247 6KY687524K |
| Refresh Digital PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | 97e83e68-6374-4df4-93f6-d707fc32748d | 2022-11-28 | Warnings | 6OZP39ZG8H |
| Refresh Digital | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | b2bd34d4-fab9-4f4b-9be2-5d30b55f5b81 | 2022-11-28 | Warnings | 6OZP39ZG8H |
| Glimepiride | GLIMEPIRIDE | Proficient Rx LP | beb0cefb-807b-4cc3-ada2-7a8ed4aa8f2b | 2022-10-01 | Warnings, Adverse reactions | 199246 6KY687524K |
| Glimepiride | GLIMEPIRIDE | Proficient Rx LP | 5a5747ea-cded-49ed-8807-dd3e2a1159e0 | 2022-10-01 | Warnings, Adverse reactions | 199245 6KY687524K |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.